Serum Levels of Urokinase Plasminogen Activator Receptor (suPAR) Discriminate Moderate Uncontrolled from Severe Asthma

Introduction: The most clinically useful concept in asthma is based on the intensity of treatment required to achieve good asthma control. Biomarkers to guide therapy are needed. Aims: To investigate the role of circulating levels of soluble urokinase plasminogen activator receptor suPAR as a marker...

Descripción completa

Detalles Bibliográficos
Autores principales: Kotsiou, Ourania S., Pantazopoulos, Ioannis, Mavrovounis, Georgios, Marsitopoulos, Konstantinos, Tourlakopoulos, Konstantinos, Kirgou, Paraskevi, Daniil, Zoe, Gourgoulianis, Konstantinos I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693242/
https://www.ncbi.nlm.nih.gov/pubmed/36579490
http://dx.doi.org/10.3390/jpm12111776

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693242/
https://www.ncbi.nlm.nih.gov/pubmed/36579490
http://dx.doi.org/10.3390/jpm12111776

Ejemplares similares